Pharma and Biotech
Appointment of Hybridan as Adviser | 18-Mar-2024 | 07:00 | RNS |
Directorate Appointment | 29-Feb-2024 | 07:02 | RNS |
Directorate Changes | 29-Feb-2024 | 07:01 | RNS |
Total Voting Rights | 29-Feb-2024 | 07:00 | RNS |
TR-1: NOTIFICATION OF MAJOR HOLDINGS | 28-Feb-2024 | 17:35 | RNS |
TR-1: NOTIFICATION OF MAJOR HOLDINGS | 28-Feb-2024 | 17:34 | RNS |
TR-1: NOTIFICATION OF MAJOR HOLDINGS | 28-Feb-2024 | 17:34 | RNS |
Directors’ Dealings | 26-Feb-2024 | 13:07 | RNS |
Result of General Meeting | 19-Feb-2024 | 13:52 | RNS |
Completion of Capital Reorganisation | 16-Feb-2024 | 07:00 | RNS |
Subscription | 15-Feb-2024 | 07:00 | RNS |
Capital Reorganisation | 14-Feb-2024 | 12:53 | RNS |
Notice of General Meeting & Posting of Circular | 02-Feb-2024 | 15:17 | RNS |
Convertible Loan Note Agreements | 02-Feb-2024 | 15:13 | RNS |
Fundraising and Proposed Capital Reorganisation | 30-Jan-2024 | 07:04 | RNS |
Currency | UK Pounds |
Share Price | 0.43p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 1.45 |
52 Week Low | 0.41 |
Volume | 1,211,781 |
Shares Issued | 1,088.42m |
Market Cap | £4.68m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:00 | 64 @ 0.45p |
15:53 | 500,000 @ 0.42p |
15:40 | 2,211 @ 0.45p |
15:00 | 857 @ 0.45p |
14:17 | 66,698 @ 0.42p |
CEO | Clarissa Ann Sowemimo- Coke |
You are here: research